3,817 companies
12,975 AI summaries
9,784 risk analyses
5,404 growth scores
Register free — watchlist & alerts →
🔔 Get free email alerts on Nxera Pharma Co., Ltd. (4565)
AI summaries of Japanese EDINET filings — in English. Free, unsubscribe anytime.
- ✓ Email alert when 4565 files its next EDINET disclosure
- ✓ AI summary · sentiment · risk · growth (JA / EN)
- ✓ Free account: watchlist & alerts on all the stocks you follow
EDINET 4565 Out of Scope
Nxera Pharma Co., Ltd.
Large Shareholding Report (Special Exception Securities) ／ 2026-11-09 14:50
Covers EDINET statutory filings (TDNET timely disclosures / earnings flashes are not included).
📊 Large-shareholding (5%) report
Holder: Goldman Sachs
Stake: 0.00%
Change: New
Purpose:
Trading and securities borrowing as part of securities-related business operations
🧩 5% holders of this company (2 holders · 14.94%)
| Holder | Stake | Change | |
|---|---|---|---|
| Gomi Daisuke Pure | 11.67% | +1.03pp | view |
| Mizuho Securities Co., Ltd. | 3.27% | +0.49pp | view |
| Goldman Sachs | 0.00% (exited) | new | view |
Each holder’s most recent 5% filing. The sum reflects disclosed major-holder ownership, not total float.
Risk and growth scores and tags are AI-generated estimates from analyzing the disclosure. They are not guarantees of fact, nor investment advice or recommendations. Make investment decisions at your own discretion.
Track Japanese disclosures with JSIGNAL
AI summaries, risk & growth analysis, watchlist alerts and a screener for every Japanese listed company.
Start free — 30-day trial Login